Monografie
Determining the epigenetic synergy of a repurposed drug and identification of prognosis-related lncRNAs in liver cancer and hematologic malignancies
- Sprache
-
Englisch
- Identifier
-
1315507374
Thema
Krebs
Beteiligte Personen und Organisationen
Wang, Yulu
Schmidt-Wolf, Ingo
Weiher, Hans
Schmidt-Wolf, Ingo
Weiher, Hans
- URN
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.02.2024, 11:10 MEZ
Objekttyp
- Monografie
Beteiligte
- Wang, Yulu
- Schmidt-Wolf, Ingo
- Weiher, Hans
Ähnliche Objekte (12)
Optimizing epigenetic therapies of hematological malignancies : identification of novel epigenetic biomarkers and mechanistic study of 5-aza-2'-deoxycytidine
Epigenetic aberrations and cancer
Novel epigenetic biomarkers for diagnosis, prognosis and response prediction in colorectal cancer
Identification of protein markers in tissue & liquid biopsies for improving early diagnosis & prognosis of sporadic colorectal cancer
Modulation of apoptosis and signalling in cancer cells after treatment with epigenetic modulators
The risk of developing subsequent primary malignancies among adult patients with lymphatic and haematopoietic malignancies in Germany : a pooled analysis of Cancer Registry Data (1990–2011)
Mutational processes of thoracic malignancies
Increase in Efficacy of Checkpoint Inhibition by Cytokine-Induced-Killer Cells as a Combination Immunotherapy for Renal Cancer
Targeted therapy of DC-CIK cells in renal cell carcinoma
Necroptosis microenvironment directs lineage commitment in liver cancer
Identification of translocations in single disseminated cancer cells
Development and validation of gene signatures predicting the prognosis for serous ovarian cancer patients
Optimizing epigenetic therapies of hematological malignancies : identification of novel epigenetic biomarkers and mechanistic study of 5-aza-2'-deoxycytidine
Epigenetic aberrations and cancer
Novel epigenetic biomarkers for diagnosis, prognosis and response prediction in colorectal cancer
Identification of protein markers in tissue & liquid biopsies for improving early diagnosis & prognosis of sporadic colorectal cancer
Modulation of apoptosis and signalling in cancer cells after treatment with epigenetic modulators
The risk of developing subsequent primary malignancies among adult patients with lymphatic and haematopoietic malignancies in Germany : a pooled analysis of Cancer Registry Data (1990–2011)
Mutational processes of thoracic malignancies
Increase in Efficacy of Checkpoint Inhibition by Cytokine-Induced-Killer Cells as a Combination Immunotherapy for Renal Cancer
Targeted therapy of DC-CIK cells in renal cell carcinoma
Necroptosis microenvironment directs lineage commitment in liver cancer
Identification of translocations in single disseminated cancer cells
Development and validation of gene signatures predicting the prognosis for serous ovarian cancer patients
Optimizing epigenetic therapies of hematological malignancies : identification of novel epigenetic biomarkers and mechanistic study of 5-aza-2'-deoxycytidine
Epigenetic aberrations and cancer
Novel epigenetic biomarkers for diagnosis, prognosis and response prediction in colorectal cancer
Identification of protein markers in tissue & liquid biopsies for improving early diagnosis & prognosis of sporadic colorectal cancer
Modulation of apoptosis and signalling in cancer cells after treatment with epigenetic modulators
The risk of developing subsequent primary malignancies among adult patients with lymphatic and haematopoietic malignancies in Germany : a pooled analysis of Cancer Registry Data (1990–2011)
Mutational processes of thoracic malignancies
Increase in Efficacy of Checkpoint Inhibition by Cytokine-Induced-Killer Cells as a Combination Immunotherapy for Renal Cancer
Targeted therapy of DC-CIK cells in renal cell carcinoma
Necroptosis microenvironment directs lineage commitment in liver cancer
Identification of translocations in single disseminated cancer cells